Dr. Goodarzi is a gastrointestinal and liver pathologist at Miraca Life Sciences’ Newton, Massachusetts site. He completed his GI/liver pathology training at New York Presbyterian Hospital–Weill Cornell Medical Center, and was an Assistant Professor of Pathology at MD Anderson Cancer Center before joining Miraca Life Sciences.
Dr. Goodarzi completed a post-doctoral research fellowship in immunology at Harvard Medical School in the Department of Pathology. His residency training was in Anatomic Pathology at the University of Massachusetts Memorial Medical Center. This was followed by a Gastrointestinal and Liver Pathology fellowship at New York Presbyterian Hospital–Weill Cornell Medical Center and a General Surgical Pathology fellowship at MD Anderson Cancer Center. Dr. Goodarzi began his academic career as a faculty member at MD Anderson Cancer Center, where he was an Assistant Professor of Pathology. His daily diagnostic work at MD Anderson included consultations and expert second opinions on complicated gastrointestinal and liver cancer cases. Dr. Goodarzi joined Miraca Life Sciences in 2009, where he continues to pursue research interests that include Barrett’s esophagus and the use of molecular markers in the gastrointestinal tract. He has authored and co-authored multiple abstracts and peer-reviewed journal articles, including a chapter in Advances in Surgical Pathology that reviewed the use of molecular prognostic markers in gastric carcinoma. Dr. Goodarzi is a Diplomate of the American Board of Pathology with certification in Anatomic Pathology and an active member of the College of American Pathologists.